Influence of Cardiac Implantable Electronic Devices on the Hemostatic System

CompletedOBSERVATIONAL
Enrollment

250

Participants

Timeline

Start Date

March 1, 2020

Primary Completion Date

November 1, 2023

Study Completion Date

November 1, 2023

Conditions
ThromboembolismCardiac EventHemostatic Disorder
Interventions
PROCEDURE

Cardiac implantable electronic device implantation.

Patients who have indications will receive cardiac implantable electronic device implantation.

PROCEDURE

Cardiac implantable electronic device replace.

Patients who have indications will receive cardiac implantable electronic device replace.

DIAGNOSTIC_TEST

Duplex ultrasound.

Patients will undergo ultrasound examination of the vessels of the upper and lower extremities.

DIAGNOSTIC_TEST

Echocardiography.

Patients will undergo an ultrasound examination of the heart.

DIAGNOSTIC_TEST

Blood sampling.

Patients will be taken venous blood to determine the studied markers of hemostasis system.

Trial Locations (1)

Unknown

Ryazan State Medical University, Ryazan

All Listed Sponsors
lead

Ryazan State Medical University

OTHER

NCT04499612 - Influence of Cardiac Implantable Electronic Devices on the Hemostatic System | Biotech Hunter | Biotech Hunter